TipRanks
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market

Telomir Pharmaceuticals, Inc. (TELO) Balance Sheet

214 Followers

Telomir Pharmaceuticals, Inc. Balance Sheet

Telomir Pharmaceuticals, Inc.'s total assets for Q2 2026 were $5.37M, a decrease of -7.32% from the previous quarter. TELO total liabilities were $332.42K for the fiscal quarter, a -59.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 7.34M$ 1.32M$ 4.77M$ 48.73K$ 55.00K
Total Liabilities
$ 1.43M$ 680.97K$ 1.34M$ 986.01K$ 138.13K
Total Equity Gross Minority
$ 5.91M$ 643.04K$ 3.44M$ -937.28K$ -83.13K
Other Metrics
Currency in USD

Telomir Pharmaceuticals, Inc. Debt to Assets